Mark C. Petrie

5 ta ish

University of Glasgow

1. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

   John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi +35

   Maqola20196 iqtibos

   ABIABI:AkademIndex/2026.other.282514

2. Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy

   Karen Sliwa, Denise Hilfiker‐Kleiner, Mark C. Petrie +15

   Sharh maqolaOAOchiq kirish20103 iqtibos

   ABIABI:AkademIndex/2026.other.115010

3. Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy

   Johann Bauersachs, Tobias König, Peter van der Meer +19

   MaqolaOAOchiq kirish20193 iqtibos

   ABIABI:AkademIndex/2026.other.115016

4. Heart Failure and Chronic Obstructive Pulmonary Disease: Diagnostic Pitfalls and Epidemiology

   Nathaniel M. Hawkins, Mark C. Petrie, Pardeep S. Jhund +3

   Sharh maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.295790

5. Pregnancies in women after peri-partum cardiomyopathy: the global European Society of Cardiology EuroObservational Research Programme Peri-Partum Cardiomyopathy Registry

   Karen Sliwa, Alice M. Jackson, Charle Viljoen +17

   MaqolaOAOchiq kirishCardiovascular Issues in PregnancyEuropean Heart Journal20250 iqtibos

   ABIABI:AkademIndex/2025.article.000122